They are not intended for human consumption, clinical use, therapeutic application, diagnosis, treatment, cure, or prevention of any disease
For patients with type 2 diabetes, Semaglutide GLP-1 injections help regulate insulin release in response to food, lower the amount of glucagon (a hormone that raises blood sugar levels), and slow down gastric emptying to enhance feelings of fullness
C., Dayanithi, G
A push uses IV access but delivers a smaller volume over a shorter visit than a saline-based drip
So, no matter your semaglutide dose, which type you're taking, or whether you're taking it for type 2 diabetes or obesity, there's a chance you'll be hit with nausea
The EMA, as well as the FDA in the US, have approved labelling for Wegovy that mentions that semaglutide has been shown to cause thyroid tumours in rodents, and the US regulator has said the drug should not be used in people with a family history of thyroid cancer